New at AACR 2017 | Poster Presentations | In-Booth Poster Hall
Accelerate oncology drug discovery and development
With physiologically relevant tumor models that reflect in vivo complexity
Visit InSphero at the AACR 2017 Annual Meeting to learn how our 3D InSight™ Oncology Services can help you accelerate development of anti-cancer drugs and immuno-therapeutic strategies, using 3D tumor spheroid models that more accurately reflect the complex biology of tumor microenvironments. We’ll also be previewing our new GravityTRAP™ 384 Microtissue Platform, a first-of-its-kind 384-well platform for high-throughput and high content imaging designed and optimized specifically for use with spheroids. Visit one of our posters, or join us at Booth 1029 to browse our in-booth poster hall.
What’s New at AACR 2017
3D InSight™ Immuno-oncology
Assess immune cell infiltration and tumor cell killing in vitro
The InSphero 3D InSight™ Oncology Services team can guide you through preclinical in vitro evaluation of your immuno-therapeutics in physiologically relevant 3D tumor microtissues. Our 3D experts can build complex tumor spheroid models comprised of tumor, stromal, and immune components with the reproducibility required to ensure assay consistency and confidence in data interpretation.
Potential applications include:
- Immune cell infiltration
- Tumor cell killing
- Checkpoint inhibitor efficacy
- Mono-or multi-specific antibody efficacy
- Immuno-modulator activity
Sneak Peek: GravityTRAP™ 384 Microtissue Platform
Achieve superior HCI in 3D tumor spheroids
At AACR 2017, we’ll be previewing our new GravityTRAP™ 384 Microtissue Platform, a spheroid-optimized high-throughput format for tumor microtissues compatible with today’s state-of-the-art liquid handling and high content imaging systems. You’ll soon be able to harness the benefits of working in more physiologically relevant 3D tumor spheroid models without the fear of aspirating your microtissues and with a flat glass base plate for superior imaging. Watch the video then stop by our booth to learn more.
Your 3D InSight™ Conference Planner
Conference Dates
April 1-5, 2017
Venue
Walter E. Washington Convention Center, Washington, DC USA
Booth
1029
Download the AACR Meeting App
View the AACR Online Meeting Planner
Poster Presentations
See how the InSphero 3D Select™ Process is being applied to personalized therapeutic approaches for cancer
Wednesday April 5, 8:00 AM – 12:00 PM
5781/17 (Section 38): Establishment of a 3D ex-vivo assay as a preclinical drug testing platform for personalized cancer therapy
Presented by Dr. Sumeer Dhar, InSphero AG in collaboration with University of Zurich
Wednesday April 5, 8:00 AM – 12:00 PM
5780/16 (Section 38): 3D ex-vivo assay platform using primary lung cancer cells in malignant pleural effusions as predictors for clinical outcome of personalized chemotherapy
Presented by Cheng-guang Wu, University of Zurich
In-booth Poster Hall
Accelerate Drug Discovery and Development with InSphero’s Oncology Platform
Evaluate efficacy of immuno-therapeutics in biologically relevant 3D cancer microtissue models
Multi-parametric 3D tumor microtissue-based phenotypic compound classification
Assessment of tumor recurrence with an in vitro 3D tumor microtissue model